January 8, 2016 11:32am
After repeated denials, they wouldn’t need to raise capital - SELL
If and when a financing expect a -20% reduction in share pricing
BLFS flies for future capital market access after announcing preliminary full year 2015 revenue of $6.4 million, including a 30% increase in core biopreservation media revenue over the prior year.
Cash position was $5.25 M as of 9/30.15
BLFS closed at $2.10 and is UP +$0.03, Friday a.m. Where has the share price gone all year, 1/2/15 started out at $1.64; the last high was $2.79 on 6/30 and 2016 closed at $2.17.
The 52 week range was or is $1.50 to $4.44. On 3/25/14 BLFS raised $15.4 M unit financing of 3. <$13.6 M after expense> after converting 14.3 M of debt to equity . Each unit included one share and one warrant at with warrants priced at $4.30.
With the outstanding warrants hanging at an unrealized pricing – an overhang still exits.
